Related Experiment Video
Updated: Jun 26, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
[Oncogenic and tumour suppressor microRNAs]
Anne-Laure Finoux1, Pascal Chartrand
1Département de Biochimie, Université de Montréal, 2900, Edouard-Montpetit, Montréal, Québec, H3C 3J7 Canada.
Abstract:
microRNAs constitute one of the most important discovery in the past few years in the field of gene expression regulation. They can precisely regulate the expression of a specific protein by inhibiting its translation and/or promoting the degradation of its mRNA. In several cancers, the expression of some microRNAs is misregulated, pointing toward the existence of microRNAs with oncogenic or tumour suppressor properties. The miR-17-92 miRNA cluster has been reported to have a pro-oncogenic role in a mouse model system of Myc-induced B cell lymphoma. Some of its targets mRNAs code for proteins with pro-apoptotic or anti-proliferative functions, which shed some light on the mechanism of action of this cluster. On the other hand, a tumour suppressor miRNA like let-7 targets mRNAs coding for oncogenes and is frequently down-regulated in cancers. The finding that c-Myc controls the expression of several of these microRNAs reveals new information on how misregulation of this proto-oncogene can promote tumorigenesis.
Insights
MicroRNAs regulate gene expression and can act as oncogenes or tumor suppressors in cancer. The miR-17-92 cluster promotes tumors by targeting apoptosis and proliferation genes, while c-Myc influences these microRNAs.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression, impacting protein translation and mRNA degradation.
- Dysregulated miRNA expression is implicated in various cancers, suggesting roles as oncogenes or tumor suppressors.
- The miR-17-92 cluster has demonstrated oncogenic properties in Myc-induced B cell lymphoma models.
Purpose of the Study:
- To elucidate the role of microRNAs in cancer development and gene regulation.
- To investigate the oncogenic mechanisms of the miR-17-92 cluster.
- To understand how c-Myc proto-oncogene misregulation contributes to tumorigenesis via miRNA control.
Main Methods:
- Analysis of miRNA expression patterns in cancer.
- Identification of miRNA targets involved in apoptosis and cell proliferation.
- Investigation of the regulatory relationship between c-Myc and specific microRNAs.
Main Results:
- The miR-17-92 cluster targets mRNAs encoding proteins that inhibit apoptosis and promote proliferation, contributing to its oncogenic role.
- Tumor suppressor miRNAs, such as let-7, target oncogenes and are often downregulated in cancers.
- c-Myc was found to control the expression of several microRNAs, linking its proto-oncogenic activity to miRNA dysregulation.
Conclusions:
- MicroRNAs play critical roles in tumorigenesis, acting as either oncogenes or tumor suppressors.
- The miR-17-92 cluster promotes cancer progression through specific gene targeting.
- c-Myc's influence on miRNA expression provides a novel mechanism for its oncogenic function.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

